Yanyun Pan

Yanyun Pan

Auto-generated profile, based on publicly available information

Yanyun Pan

Department of Cardiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2023 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
YPYanyun Pan
Yanyun Pan
JYJinxiu Yang
Jinxiu Yang
JDJin Dai
Jin Dai
XXXiaoming Xu
Xiaoming Xu
XZXinbin Zhou
Xinbin Zhou
WMWei Mao
Wei Mao
Background: Cardiac hypertrophy is an initiating link to Heart failure (HF) which still seriously endangers human health. Transferrin receptor (TFRC), which promotes iron uptake through the transferrin cycle, is essential for cardiac function. However, whether TFRC is involved in the process of pathological cardiac hypertrophy is not clear.Methods: Transverse aortic constriction (TAC) mouse model and mice primary cardiomyocytes treated with isoproterenol (ISO) or phenylephrine (PHE) were used to mimic cardiac hypertrophy in vivo and in vitro. Single cell RNA sequence data from heart tissues of TAC‐model mice was obtained from the Gene Expression Omnibus (GEO) database, and was analyzed with R package Seurat. TFRC expression and macrophage infiltration in the heart tissue were tested by immunofluorescent staining. Macrophage polarization was detected by Flow Cytometry. TFRC expressions were detected by qRT‐PCR, Western blot, and ELISA.Results: TFRC expression is increased in the pathological cardiac hypertrophy of mice model and positively associated with macrophage infiltration. Furthermore, TFRC in cardiomyocytes recruits and activates macrophages by secreting C‐C motif ligand 2 (Ccl2) in the mice heart tissue with TAC surgery or in the primary cardiomyocytes stimulated with ISO or PHE to induce myocardial hypertrophy in vitro. Moreover, we find that TFRC promotes Ccl2 expression in cardiomyocytes via regulating signal transducer and activator of transcription 3 (STAT3). In addition, we find that increased TFRC expression in the HF tissue is regulated by hypoxia‐inducible factor‐1α (HIF‐1α).Conclusion: This in‐depth study shows that TFRC in cardiomyocytes promotes HF development through inducing macrophage infiltration and activation via the STAT3‐Ccl2 signaling, and TFRC expression in cardiomyocytes is regulated by HIF‐1α during HF. This study first uncovers the role of TFRC in cardiomyocytes on macrophage infiltration and activation during HF.

11 October 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JYJin-Xiu Yang
Jin-Xiu Yang
BCBin Chen
Bin Chen
YPYan-Yun Pan
Yan-Yun Pan
JHJie Han
Jie Han
Fei ChenFei Chen
Fei Chen
SHShen-Jiang Hu
Shen-Jiang Hu
New vessel formation plays a pivotal role in the pathogenesis of neovascular-related diseases. Endothelial progenitor cells (EPCs) were found to contribute to neovascular-related diseases and interference with EPC neovascularization may be a novel target for these diseases. Zoledronate (Zol) was reported to exhibit anti-angiogenic effect. Basing on these evidences, we proposed that Zol may affect EPC function to exert novel anti-angiogenic effect. In this study, we therefore investigated the effects of Zol on multiple aspects of EPC function and explored the underlying mechanisms involved. EPCs were cultured from bone marrow derived mononuclear cells. The potential effects of Zol on Angiotensin II (Ang II)-stimulated EPC proliferation, migration, adhesion, in vitro tube formation were investigated. The results showed that Ang II (1 µM) enhanced EPC migration, adhesion, in vitro tube formation but had no effect on cell proliferation. Zol (75 and 100 µM) inhibited proliferation of EPCs and 50 µM geranylgeranyol (GGOH) could reverse the decrease of EPC proliferation. We found for the first time that Zol (50–100 µM) dose dependently attenuated migration, adhesion, and in vitro tube formation of EPCs stimulated by Ang II. GGOH could reverse the attenuation of EPC function induced by Zol. However, Zol did not induce EPC apoptosis. In addition, the underlying mechanisms were determined. The results revealed that Zol markedly down-regulated active RhoA stimulated by Ang II and inhibited the phosphorylation of Erk1/2 and JNK. Moreover, RhoA silencing resulted in a notable inhibition of EPC in vitro tube formation, suggesting that RhoA suppression played a pivotal role in Zol antiangiogenic effect. These findings suggested that Zol attenuated the promotion of EPC function stimulated by Ang II and exhibited novel antiangiogenic effect via RhoA and MAPK signaling. Thus, Zol may be served as a novel therapeutic agent for neovascular-related diseases treatment.

8 August 2019 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
YPYan‐Yun Pan
Yan‐Yun Pan
JYJin‐Xiu Yang
Jin‐Xiu Yang
WMWei Mao
Wei Mao
XWXing‐Xiang Wang
Xing‐Xiang Wang

1 January 2024 in Mediators of Inflammation
Verified
Journal Article
Open access
XXXiaoming Xu
Xiaoming Xu
YWYuteng Wu
Yuteng Wu
YXYifei Xu
Yifei Xu
WMWei Mao
Wei Mao
YPYanyun Pan
Yanyun Pan
Background. Atherosclerosis is an inflammatory cardiovascular disease. However, whether the association of immune cells in plaques promotes the progression of this disease has not yet been completely elucidated. Materials and Methods. Thus, this study aimed to investigate the relationship between C1q+ macrophages and CD8T cells through scRNA‐seq data reanalysis, quantitative real‐time PCR, and flow cytometry. Chromatin immunoprecipitation‐quantitative polymerase chain reaction, western blot, and antibody‐blocking experiments were performed to investigate the role of macrophage–CD8T interaction in atherosclerosis. An atherosclerotic mouse model was developed to confirm our findings. Results. Mechanistically, Spi1 expression induced by granulocyte–macrophage colony‐stimulating factor promoted C1q expression in the macrophages. Moreover, C1q+ macrophages suppressed CD8T cell apoptosis by upregulating Slc7a7 expression to enhance the L‐arginine uptake of CD8T cells. CD8T‐derived interferon‐γ promoted macrophage activation to induce atherosclerosis. Blockade of the C1q–C1qbp axis attenuated atherosclerosis. Conclusion. In conclusion, macrophages interacting with CD8T promote atherosclerosis development via the C1q–C1qbp axis.


22 November 2024 in Medicine
Verified
Journal Article
Open access
YPYanyun Pan
Yanyun Pan
JDJin Dai
Jin Dai
MJMinwei Jin
Minwei Jin
QZQiujun Zhou
Qiujun Zhou
XJxiaoliang jin
xiaoliang jin
JZJinjie Zhang
Jinjie Zhang
Transcription factors play a crucial role in the biosynthesis of tanshinones, which are significant secondary metabolites derived from Salvia miltiorrhiza, commonly known as Danshen. These compounds have extensive pharmacological properties, including anti-inflammatory and cardioprotective effects. This review delves into the roles of various transcription factor families, such as APETALA2/ethylene response factor, basic helix-loop-helix, myeloblastosis, basic leucine zipper, and WRKY domain-binding protein, in regulating the biosynthetic pathways of tanshinones. We discuss the emerging mechanisms by which these transcription factors influence the synthesis of tanshinones, both positively and negatively, by directly regulating gene expression or forming complex regulatory networks. Additionally, the review highlights the potential applications of these insights in enhancing tanshinone production through genetic and metabolic engineering, setting the stage for future advancements in medicinal plant research.